←
Ang Cui, Ph.D.278 posts
Ang Cui, Ph.D. avatar

Ang Cui, Ph.D.

@AngCuiPhD
◷ Joined April 2023▧ 27 Photos and videos
Ang Cui, Ph.D. avatar
Ang Cui, Ph.D.@AngCuiPhD·31 Dec 2024

Happy to share our publication on a single-cell atlas of human liver immune (myeloid) cells in #HCVCure in the @JHepatology ! A tribute to one of the most remarkable medical breakthroughs of modern times: the #HCVCure. Since the introduction of direct-acting antivirals in 2011, hepatitis C virus (#HCV) infection has become the first chronic viral infection to be curable, with newer generation antivirals achieving a >95% success rate within just 8-12 weeks of treatment. What lessons can we learn from this success? Paper: journal-of-hepatology.eu/art… Editorial: journal-of-hepatology.eu/art… As part of a Phase 3b open-label clinical trial, we used single-cell genomics to systematically profile myeloid cells in the livers of individuals with HCV before and after viral clearance. We identified cell populations with immunoregulatory potential during active infections: ISG-high neutrophils and eosinophils were found to upregulate PD-L1 and IDO1, respectively, and proliferating dendritic cells increased post-cure. Further, we identified a correlation between pre-treatment viral load and the post-cure host immune state. We hope the data will inspire the development of immunotherapeutic strategies for other infections that currently lack a cure. Acknowledging our incredible team for making this work possible @nalatrak, #BoLi, @raychungmd, #NirHacohen, #MichaelWallace, #AnnaGonye, #ChrisOetheimer, #HaileyPatel, @PierreTonnerre, #GeorgLauer, and many others. @broadinstitute @MGHMedicine @harvardmed #HCV #Liver #Infections #ImmuneCells #SingleCell #DirectActingAntivirals #DAAs

Post attachment
Edward Chuong avatar
⟳ Ang Cui, Ph.D. retweeted
Edward Chuong@edchuong·12 Dec 2024

I’m excited to share our latest study led by @GiuliaPasquesi out today in @CellPressNews , uncovering a new way transposons have been repurposed for human interferon signaling! Read on for a thread on cryptic splice variants, decoy receptors, and viruses (1/N) 👇🧵

Post attachment
Michael Fischbach avatar
⟳ Ang Cui, Ph.D. retweeted
Michael Fischbach@mfgrp·11 Dec 2024

Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @DjenetBousbaine led the charge... @Nature 1/55

Post attachment
The Nobel Prize avatar
⟳ Ang Cui, Ph.D. retweeted
The Nobel Prize@NobelPrize·8 Oct 2024

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.”

Post attachment
Alex Chudnovskiy 🇺🇦 avatar
⟳ Ang Cui, Ph.D. retweeted
Alex Chudnovskiy 🇺🇦@ChudnovskiyLab·7 Oct 2024

I am happy to share a large part of my postdoctoral work published in @SciImmunology! Using LIPSTIC, we identify and characterize antigen-presenting dendritic cells (DCs) in the tumor-draining lymph node and tumor microenvironment science.org/doi/10.1126/scii…

Ivan Zanoni avatar
⟳ Ang Cui, Ph.D. retweeted
Ivan Zanoni@Lo_Zanzi·4 Oct 2024

#SameSameButDifferent! Chudnovskiy @victora_lab &co use #LIPSTIC @SciImmunology to show that only a fraction of DCs interact & activate T cells in the tumor draining lymph node & tumor microenvironment & found IL-27 potentiate anti-tumor T cell responses! Doi.org/10.1126/sciimmunol.a…

Lindau Nobel Laureate Meetings avatar
⟳ Ang Cui, Ph.D. retweeted
Lindau Nobel Laureate Meetings@lindaunobel·13 Sep 2024

Congratulations to our Lindau Alumna 2023!😃Ang Cui also participated in one of our #LINO23 Panel Discussions mediatheque.lindau-nobel.org…

I am thrilled to have been selected by MIT Technology Review @techreview as one of the 35 Innovators Under 35 worldwide! #ImmuneDictionary #CytokinesPower #TR35 #biotech technologyreview.com/innovat…